From CNBC · Gerry Smith,Brad Quick · · 3m
TL;DR: Pompe drug shortage leaves patients without critical infusions
A three-month supply disruption of Sanofi's Pompe disease treatments has forced patients to cancel infusions, raising fears of irreversible health decline.
Sanofi's Pompe disease drug shortage has lasted over three months due to manufacturing issues at its Ireland facility, forcing patients to miss critical infusions and raising concerns about permanent health damage. A three-month supply disruption of Sanofi's Pompe disease treatments has forced patients to cancel infusions, raising fears of irreversible health decline.
- Sanofi's Pompe drug shortage drags on
- What Pompe disease does to the body
- How Sanofi's drugs work
- Manufacturing problems at Ireland facility
Read the story version — the same reporting as a swipeable deck of 10 cards.





